Based on the findings reported here, we conclude that the iEκ enhancer is active in NPC cells and is further activated by LMP1 via NF-κB and AP-1 pathways, which contributes to the upregulation of Ig kappa by LMP1 in NPC cells. The gene discussed is FOS; the disease is nasopharyngeal carcinoma.